RankingsPricing
  1. US-listed companies
  2. MEDICINOVA INC
  3. Financials
  4. Stock-based compensation

MEDICINOVA INCMNOV

Market cap
$72.1M
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 20241+67.68%
Dec 31, 20231+10.61%
Dec 31, 20221-62.59%
Dec 31, 20212-45.91%
Dec 31, 20203-22.79%
Dec 31, 20194-35.03%
Dec 31, 20186+41.46%
Dec 31, 20174+12.65%
Dec 31, 20164+96.13%
Dec 31, 20152+23.65%
Dec 31, 20142+34.66%
Dec 31, 20131-97.59%
Dec 31, 201250+1.43%
Dec 31, 201150

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)